Literature DB >> 2687330

Complete and partial deficiencies of complement factor D in a Dutch family.

P S Hiemstra1, E Langeler, B Compier, Y Keepers, P C Leijh, M T van den Barselaar, D Overbosch, M R Daha.   

Abstract

A young man suffering from recurrent Neisseria infections was shown to lack detectable serum complement factor D hemolytic activity. Addition to the patient's serum of purified factor D to a final concentration of 1 microgram/ml resulted in full restoration of the activity of the alternative pathway. Using an enzyme-linked immunosorbent assay, it was shown that the patient's serum did not contain measurable amounts of factor D antigen either. The sister, the father, as well as the parents of the mother had factor D levels within the normal range, and the factor D level of the mother was decreased. The capacity of the patient's serum, at concentrations up to 5%, to promote phagocytosis of Escherichia coli by normal human granulocytes was low when compared to normal serum. Substitution of the patient's serum with purified factor D resulted in a full restoration of opsonic activity. This study describes the first complete deficiency of factor D, and demonstrates its possible relation to recurrent Neisseria infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687330      PMCID: PMC304077          DOI: 10.1172/JCI114384

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.

Authors:  R A Thompson; M H Winterborn
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

2.  C3b inactivator deficiency with immune complex manifestations.

Authors:  P Solal-Celigny; M Laviolette; J Hebert; P C Atkins; M Sirois; G Brun; G Lehner-Netsch; J M Delâge
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

3.  Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.

Authors:  M R Daha; L A Van Es
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

4.  Preparation of human factor D of the alternative pathway of complement.

Authors:  K B Reid; D M Johnson; J Gagnon; R Phohaska
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Properdin deficiency in a family with fulminant meningococcal infections.

Authors:  A G Sjöholm; J H Braconier; C Söderström
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

6.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; M R Daha; R van Furth
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

7.  Human factor D of the alternative pathway: purification and quantitation by enzyme amplified electroimmunoassay.

Authors:  L Truedsson; G Sturfelt
Journal:  J Immunol Methods       Date:  1983-10-14       Impact factor: 2.303

8.  Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.

Authors:  M R Daha; R M Bertina; J Thompson; R H Kauffmann; A Nicholson-Weller; J J Veltkamp; E Briët
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Complement components in 100 newborns and their mothers determined by electroimmunoassay.

Authors:  U Johnson; L Truedsson; B Gustavii
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1983-04

10.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Contribution of Adipose-Derived Factor D/Adipsin to Complement Alternative Pathway Activation: Lessons from Lipodystrophy.

Authors:  Xiaobo Wu; Irina Hutson; Antonina M Akk; Smita Mascharak; Christine T N Pham; Dennis E Hourcade; Rebecca Brown; John P Atkinson; Charles A Harris
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

3.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 4.  Severe infectious diseases of childhood as monogenic inborn errors of immunity.

Authors:  Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

5.  A family with complement factor D deficiency.

Authors:  D H Biesma; A J Hannema; H van Velzen-Blad; L Mulder; R van Zwieten; I Kluijt; D Roos
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 6.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 7.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Hereditary C6 deficiency in a strain of PVG/c rats.

Authors:  P L Leenaerts; R K Stad; B M Hall; B J Van Damme; Y Vanrenterghem; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

9.  Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency.

Authors:  C A Fijen; B H Derkx; E J Kuijper; M Mannens; S R Poort; M Peters; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.

Authors:  Yuzhou Zhang; Adam Keenan; Dao-Fu Dai; Kristofer S May; Emily E Anderson; Margaret A Lindorfer; John B Henrich; Gabriella R Pitcher; Ronald P Taylor; Richard Jh Smith
Journal:  JCI Insight       Date:  2020-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.